Concepedia

Publication | Closed Access

Use of the Selective Serotonin 3 Receptor Antagonist Ondansetron in the Treatment of Neuroleptic-Induced Tardive Dyskinesia

DOI

81

Citations

9

References

2000

Year

P. Sirota, Tanya Mosheva, H. Shabtay, Nir Giladi, Amos D. Korczyn
American Journal of Psychiatry

Abstract

Ondansetron may be an effective and safe therapy to control tardive dyskinesia and psychosis in patients with schizophrenia.

References

YearCitations

Page 1